Majesty Therapeutics, Inc.

CIK 2135155 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Majesty Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
May 15, 2026D0001493152-26-023677